First Immunotherapy Success For Triple-Negative Breast Cancer


Source: Queen Mary, University of London

Summary: There is new hope for people with an aggressive type of breast cancer, as an immunotherapy trial shows for the first time that lives can be extended in people with triple-negative breast cancer.


Cancer cells

Three-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom Misteli, Ph.D., and Karen Meaburn, Ph.D. at the NIH IRP.


More Information: Peter Schmid et al, “Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer”, New England Journal of Medicine, 2018.


 

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *